News
Valley Fro Yo Shop Honors Blood Cancer Awareness Month
In honor of Blood Cancer Awareness Month, two Valley Yogurtology locations will be donating 20 percent of all proceeds to The Leukemia & Lymphoma Society’s Light The Night Walk on Wednesday, Sept. 18.
Tomorrow, stop by the following locations to help support an amazing cause:
Biltmore
2045 E. Camelback Road
Suite A16A
Phoenix, AZ 85016
(602) 468-6900
N. Scottsdale
15029 N. Thompson Peak Parkway
#B107
Scottsdale, AZ 85260
(480) 451-6900
Seeking Women Who Move the Valley Nominees
Sure, we are still a few months away from January’s Women Who Move the Valley issue, but Arizona Foothills Magazine
Valley Tradition Now Offers Reserved Seating
For the first time ever, one of the state's favorite fall traditions now conviently offers reserved seating. The Grand Canyon Railway's annual Pumpkin Patch Train, which runs every Saturday and Sunday in October from Williams, now offers reserved seating for the 90-minute-long holiday experience. Times includ 11:00 a.m., 1:00 p.m. and 3:00 p.m. Tickets are $15 for kids ages 2 to 15 and $20 for adults. Activities include a journey to a secret pumpkin patch; a haunted train car, hay bale...
Free Movies at Harkins
To commemorate its 80th anniversary, Harkins Theatres is hosting plenty of fabulous freebies this month for its supporters. Take a look:
Friday, September 13 through September 26
Guests of Harkins Theatres will receive free drink upgrades on any regularly priced fountain drink to the next largest size – and free refills on large and extra large purchases on the same-day visit.
Friday, September 20 through September 26
Join Harkins Theatres for a week of free movies. Alternating two titles per location, Harkins will show recent movie favorites at select theatres. Please visit...
FDA Approves Drug Tested by Scottsdale Healthcare and TGen
There is some very exciting medical news to share from Scottsdale Healthcare and Phoenix-based Translational Genomics Research Institute (TGen): The U.S. Food and Drug Administration has just announced that it approved Abraxane for patients with advanced pancreatic cancer, following seven years of rigorous clinical trials overseen by Scottsdale Healthcare and TGen. (
